Stay updated on AMX0035 in ALS: Phoenix Clinical Trial
Sign up to get notified when there's something new on the AMX0035 in ALS: Phoenix Clinical Trial page.

Latest updates to the AMX0035 in ALS: Phoenix Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNo significant content or structural changes detected between the two screenshots. Only minor visual adjustments (layout/formatting) appear, with core study details unchanged.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check38 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference3%

- Check46 days agoChange DetectedVersion update to v3.1.0 accompanies removal of several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and no new substantive topics added.SummaryDifference0.4%

- Check60 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. No other content changes.SummaryDifference0.2%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check74 days agoChange DetectedThe web page has been updated to include new drug information and resources related to Sodium Phenylbutyrate and Amyotrophic Lateral Sclerosis, while also changing the facility name and location details.SummaryDifference3%

Stay in the know with updates to AMX0035 in ALS: Phoenix Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMX0035 in ALS: Phoenix Clinical Trial page.